Chemed Corporation $CHE Stock Sold by Vest Financial LLC

Vest Financial LLC lessened its stake in shares of Chemed Corporation (NYSE:CHE) by 28.3% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 8,932 shares of the company’s stock after selling 3,523 shares during the quarter. Vest Financial LLC’s holdings in Chemed were worth $4,511,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB grew its position in shares of Chemed by 65.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock valued at $38,000 after buying an additional 32 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in Chemed by 9.4% in the first quarter. EverSource Wealth Advisors LLC now owns 406 shares of the company’s stock valued at $153,000 after acquiring an additional 35 shares in the last quarter. Cim LLC boosted its stake in Chemed by 1.6% in the first quarter. Cim LLC now owns 2,325 shares of the company’s stock valued at $878,000 after acquiring an additional 37 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Chemed by 2.7% during the first quarter. Blue Trust Inc. now owns 1,637 shares of the company’s stock worth $618,000 after purchasing an additional 43 shares during the last quarter. Finally, GAMMA Investing LLC grew its holdings in shares of Chemed by 7.3% during the third quarter. GAMMA Investing LLC now owns 665 shares of the company’s stock worth $336,000 after purchasing an additional 45 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Spencer Lee sold 1,000 shares of the firm’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $541.04, for a total value of $541,040.00. Following the completion of the sale, the executive vice president owned 13,912 shares in the company, valued at approximately $7,526,948.48. This trade represents a 6.71% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Kevin McNamara sold 2,000 shares of the firm’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the completion of the sale, the chief executive officer owned 70,418 shares of the company’s stock, valued at $37,991,215.18. This trade represents a 2.76% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 9,190 shares of company stock worth $4,833,160. 3.33% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CHE. Weiss Ratings upgraded Chemed from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Oppenheimer upped their target price on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a research report on Friday, July 31st. Royal Bank Of Canada upped their target price on Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Wall Street Zen upgraded Chemed from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 10th. Finally, Bank of America reaffirmed a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Two research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $554.60.

Chemed Stock Down 1.4%

CHE opened at $512.72 on Friday. The business has a 50 day moving average price of $514.99 and a two-hundred day moving average price of $475.86. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17. The company has a market cap of $6.70 billion, a PE ratio of 24.24, a P/E/G ratio of 2.09 and a beta of 0.51. Chemed Corporation has a 52 week low of $365.20 and a 52 week high of $557.00.

Chemed (NYSE:CHE) last announced its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%. The company had revenue of $673.25 million for the quarter, compared to the consensus estimate of $665.04 million. During the same period last year, the business posted $4.27 EPS. The company’s revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, research analysts anticipate that Chemed Corporation will post 23.55 EPS for the current year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th were given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date was Monday, August 17th. This is an increase from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is currently 14.06%.

About Chemed

Chemed Corporation (NYSE:CHE) is a Cincinnati, Ohio-based company that provides healthcare and residential and commercial services through two operating businesses: VITAS Healthcare and Roto-Rooter. Its operations serve customers primarily in the United States, with Roto-Rooter also providing services in Canada.

VITAS Healthcare is a provider of hospice and palliative care for individuals with advanced illnesses. The business delivers care in patients’ homes, hospice inpatient units, hospitals, nursing facilities and other care settings.